Ascentage Pharma IPO opens flat at $17.25
Ascentage Pharma (Nasdaq: AAPG) IPO opens at $17.25 after pricing 7,325,000 American depositary shares at $17.25J.P. Morgan and Citigroup led the offering
Ascentage Pharma (Nasdaq: AAPG) IPO opens at $17.25 after pricing 7,325,000 American depositary shares at $17.25J.P. Morgan and Citigroup led the offering
– Norway stocks were lower after the close on Friday, as losses in the Media, Transport and Diversified Financials sectors led shares lower. At the close in Oslo,...
By Patricia Zengerle WASHINGTON (Reuters) - Two U.S. lawmakers will keep trying to block arms sales to the United Arab Emirates, having determined that the UAE is providing...
By Foo Yun Chee BRUSSELS (Reuters) - U.S.-based International Paper secured EU clearance for its 5.8-billion-pound ($7.2 billion) acquisition of UK rival DS Smith with a pledge to...
WASHINGTON (Reuters) - U.S. consumer sentiment weakened in January for the first time in six months amid worries about the labor market and potential higher prices for goods if...
– Greece stocks were higher after the close on Friday, as gains in the Banking, Construction and Travel sectors led shares higher. At the close in Athens, the Athens...
By Libby George and Karin Strohecker LONDON (Reuters) - Foreign investors are flocking to Turkey's local debt markets, saying they are impressed by interest rate cuts and easing...
By Johann M Cherian and Sukriti Gupta (Reuters) - The benchmark S&P 500 and the Nasdaq struggled for direction on Friday, as investors avoided big bets and assessed fresh data to...
-- Shares of Diageo (LON:DGE) Plc climbed 4% Friday following reports from Bloomberg News it is reviewing a possible sale of its drinks portfolio, including...
BRUSSELS (Reuters) - BMW (ETR:BMWG) has joined Chinese producers in filing a challenge at the Court of Justice of the European Union (CJEU) against EU tariffs on China-made...